Símbolo | YTM % | Volume | Preço % | Cupom % | Data de vencimento | Montante em circulação | Valor de face | Valor mín. de denominação | Emissor |
---|---|---|---|---|---|---|---|---|---|
6,65% | 3,75 M | 67,19% | 3,18% | 2050-07-09 | 2 B USD | 1.000,00 USD | 200.000,00 USD | Takeda Pharmaceutical Co., Ltd. | |
6,61% | 200 K | 65,69% | 3,38% | 2060-07-09 | 1 B USD | 1.000,00 USD | 200.000,00 USD | Takeda Pharmaceutical Co., Ltd. | |
6,14% | 600 K | 75,37% | 3,03% | 2040-07-09 | 1,5 B USD | 1.000,00 USD | 200.000,00 USD | Takeda Pharmaceutical Co., Ltd. | |
5,85% | 1,93 M | 99,37% | 5,80% | 2064-07-05 | 500 M USD | 1.000,00 USD | 200.000,00 USD | Takeda Pharmaceutical Co., Ltd. | |
TTKPH4369980Baxalta Incorporated 5.25% 23-JUN-2045 | 5,71% | 278 K | 95,68% | 5,25% | 2045-06-23 | 500,41 M USD | 1.000,00 USD | 2.000,00 USD | Baxalta, Inc. |
5,63% | 250 K | 100,27% | 5,65% | 2054-07-05 | 600 M USD | 1.000,00 USD | 200.000,00 USD | Takeda Pharmaceutical Co., Ltd. | |
5,52% | 5,6 M | 101,21% | 5,65% | 2044-07-05 | 800 M USD | 1.000,00 USD | 200.000,00 USD | Takeda Pharmaceutical Co., Ltd. | |
5,08% | 1,2 M | 101,38% | 5,30% | 2034-07-05 | 1,1 B USD | 1.000,00 USD | 200.000,00 USD | Takeda Pharmaceutical Co., Ltd. | |
5,00% | 1,91 M | 88,03% | 2,05% | 2030-03-31 | 2,5 B USD | 1.000,00 USD | 200.000,00 USD | Takeda Pharmaceutical Co., Ltd. | |
4,67% | 600 K | 101,04% | 5,00% | 2028-11-26 | 1,73 B USD | 1.000,00 USD | 200.000,00 USD | Takeda Pharmaceutical Co., Ltd. | |
TTKPH4370840Baxalta Incorporated 4.0% 23-JUN-2025 | 4,64% | 14 K | 99,80% | 4,00% | 2025-06-23 | 800,17 M USD | 1.000,00 USD | 2.000,00 USD | Baxalta, Inc. |
UUS82481LAD1SHIRE ACQUIST.I.IE 16/26 | 4,51% | 0 | 98,08% | 3,20% | 2026-09-23 | 1,5 B USD | 1.000,00 USD | 2.000,00 USD | Shire Acquisitions Investments Ireland DAC |
4,12% | 0 | 80,02% | 2,00% | 2040-07-09 | 1 B EUR | 1.000,00 EUR | 100.000,00 EUR | Takeda Pharmaceutical Co., Ltd. | |
3,27% | 0 | 88,74% | 1,38% | 2032-07-09 | 1 B EUR | 1.000,00 EUR | 100.000,00 EUR | Takeda Pharmaceutical Co., Ltd. | |
3,01% | 0 | 99,94% | 3,00% | 2030-11-21 | 1,5 B EUR | 1.000,00 EUR | 100.000,00 EUR | Takeda Pharmaceutical Co., Ltd. | |
2,89% | 0 | 92,67% | 1,00% | 2029-07-09 | 850 M EUR | 1.000,00 EUR | 100.000,00 EUR | Takeda Pharmaceutical Co., Ltd. | |
2,73% | 0 | 95,61% | 0,75% | 2027-07-09 | 750 M EUR | 1.000,00 EUR | 100.000,00 EUR | Takeda Pharmaceutical Co., Ltd. | |
2,71% | 0 | 116,57% | 5,00% | 2028-11-26 | 22,68 M USD | 1.000,00 USD | 200.000,00 USD | Takeda Pharmaceutical Co., Ltd. | |
2,64% | 0 | 99,35% | 2,25% | 2026-11-21 | 1,5 B EUR | 1.000,00 EUR | 100.000,00 EUR | Takeda Pharmaceutical Co., Ltd. | |
SSHPG4260178Baxalta Incorporated 4.0% 23-JUN-2025 | — | — | — | 4,00% | 2025-06-23 | 303 K USD | 1.000,00 USD | 2.000,00 USD | Baxalta, Inc. |
— | — | — | 5,00% | 2028-11-26 | 22,68 M USD | 1.000,00 USD | 200.000,00 USD | Takeda Pharmaceutical Co., Ltd. |